Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

309 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Corrigendum to "Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatment" [Multiple Sclerosis and Related Disorders, Volume 79, November 2023, https://doi.org/10.1016/j.msard.2023.104949].
Sen S, Tuncer A, Terzi M, Bunul SD, Ozen-Acar P, Altunrende B, Ozakbas S, Tutuncu M, Uygunoglu U, Akman-Demir G, Karabudak R, Efendi H, Siva A. Sen S, et al. Among authors: tuncer a. Mult Scler Relat Disord. 2024 Dec;92:105917. doi: 10.1016/j.msard.2024.105917. Epub 2024 Oct 17. Mult Scler Relat Disord. 2024. PMID: 39423726 No abstract available.
Validity and reliability of the International Cooperative Ataxia Rating Scale (ICARS) and the Scale for the Assessment and Rating of Ataxia (SARA) in multiple sclerosis patients with ataxia.
Salcı Y, Fil A, Keklicek H, Çetin B, Armutlu K, Dolgun A, Tuncer A, Karabudak R. Salcı Y, et al. Among authors: tuncer a. Mult Scler Relat Disord. 2017 Nov;18:135-140. doi: 10.1016/j.msard.2017.09.032. Epub 2017 Sep 29. Mult Scler Relat Disord. 2017. PMID: 29141795
A 12-month, Open Label, Multicenter Pilot Study Evaluating Fingolimod Treatment in terms of Patient Satisfaction in Relapsing Remitting Multiple Sclerosis Patients - FINE Trial.
Demır GA, Türkoğlu R, Saıp S, Yüceyar N, Efendı H, Turan ÖF, Ağan K, Terzı M, Boz C, Tuncer A, Koçer B, Kasap M, Çalişkan Z; Fine Study Group. Demır GA, et al. Among authors: tuncer a. Noro Psikiyatr Ars. 2017 Jun 22;56(4):253-257. doi: 10.5152/npa.2017.20515. eCollection 2019 Dec. Noro Psikiyatr Ars. 2017. PMID: 31903032 Free PMC article.
Differences Between General Neurologists and Multiple Sclerosis Specialists in the Management of Multiple Sclerosis Patients: A National Survey.
Kürtüncü M, Tuncer A, Uygunoğlu U, Çalişkan Z, Paksoy AK, Efendı H, Kocaman AS, Özcan C, Terzı M, Turan ÖF, Saıp S, Karabudak R, Sıva A. Kürtüncü M, et al. Among authors: tuncer a. Noro Psikiyatr Ars. 2017 Jun 20;56(4):269-272. doi: 10.5152/npa.2017.19387. eCollection 2019 Dec. Noro Psikiyatr Ars. 2017. PMID: 31903035 Free PMC article.
Corrigendum to Myelin Oligodendrocyte Glycoprotein Antibody Associated Central Nervous System Demyelinating Disease: A Tertiary Center Experience From Turkey [Multiple Sclerosis and Related Disorders 44 (2020) 102376].
Inan B, Gocmen R, Vural A, Colpak AI, Meinl E, Karabudak R, Tuncer A. Inan B, et al. Among authors: tuncer a. Mult Scler Relat Disord. 2021 Feb;48:102581. doi: 10.1016/j.msard.2020.102581. Epub 2020 Oct 20. Mult Scler Relat Disord. 2021. PMID: 33593587 No abstract available.
The outcome of a national MS-Covid-19 study: What the Turkish MS cohort reveals?
Sen S, Karabudak R, Schiavetti I, Demir S, Ozakbas S, Tutuncu M, Petek Balci B, Turan OF, Uzunkopru C, Koseoglu M, Yetkin MF, Gunduz T, Gumus H, Kale Icen N, Carmisciano L, Terzi M, Acar P, Gungor Dogan I, Baba C, Tuncer A, Uygunoglu U, Sormani MP, Efendi H, Siva A; Turkish MS Study Group. Sen S, et al. Among authors: tuncer a. Mult Scler Relat Disord. 2021 Jul;52:102968. doi: 10.1016/j.msard.2021.102968. Epub 2021 Apr 18. Mult Scler Relat Disord. 2021. PMID: 33940495 Free PMC article.
309 results